Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Total Revenue
174,386
184,305
154,961
139,118
Cost of Revenue
99,036
96,855
87,290
80,240
Gross Profit
75,350
87,450
67,671
58,878
Operating Expenses
Research Development
2,730
10,722
7,409
11,423
Selling General and Administrative
14,112
28,493
19,038
16,519
Non Recurring
--
1,100
545
2,127
Others
8,293
(1,100)
0
0
Total Operating Expenses
25,135
39,215
26,992
30,069
Operating Income or Loss
50,215
48,235
40,679
28,809
Income from Continuing Operations
Total Other Income/Expenses Net
(16,878)
4,611
913
737
Earnings Before Interest And Taxes
33,337
52,846
41,592
29,546
Interest Expense
22,842
20,686
20,912
20,720
Income Before Tax
10,495
32,160
20,680
8,826
Income Tax Expense
(2,275)
18,138
7,423
3,100
Minority Interest
--
--
--
0
Net Income From Continuing Ops
12,770
14,022
13,257
5,726
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
12,770
14,022
13,257
5,726
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
12,770
14,022
13,257
5,726